Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2835514 | 0.89 | CETP (0.63) | CETPKCNH2 | |
| SCHEMBL13204322 | 0.83 | CETP (0.51) | CETPKCNH2 | |
| SCHEMBL13984145 | 0.80 | CETP (0.54) | CETPKCNH2 | |
| SCHEMBL13204552 | 0.80 | CETP (0.48) | CETPKCNH2 | |
| SCHEMBL13204466 | 0.79 | CETP (0.51) | CETPKCNH2 | |
| SCHEMBL13984154 | 0.79 | CETP (0.57) | CETPKCNH2 | |
| SCHEMBL13984061 | 0.79 | CETP (0.60) | CETPKCNH2 | |
| SCHEMBL13204555 | 0.79 | CETP (0.55) | CETPKCNH2 | |
| SCHEMBL13204344 | 0.78 | CETP (0.58) | CETPKCNH2 | |
| SCHEMBL13984060 | 0.78 | CETP (0.50) | CETPKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197630-A1 | CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES | MERCK & CO., INC | 2010-08-05 | — | — | US | disclosed |
| WO-2008156717-A1 | CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES | MERCK & CO., INC. (US) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197630-A1 | CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES | CETP, APOB, MTTP | CETP 1/4885KCNH2 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.